SAT0211 Real world data of rituximab effectiveness in rheumatoid arthritis: differences between biologic-naive patients and previously exposed to biologics
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.4494
Abstract: Background Rituximab is only approved for rheumatoid arthritis (RA) treatment in patients with an incomplete response or intolerance to others DMARDs, including TNF alfa inhibitors. It represents a significant advance in RA biologics arsenal due… read more here.
Keywords: rituximab; response; patients previously; exposed biologics ... See more keywords